These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15352031)

  • 21. Chemoresistance to 5-fluorouracil induces epithelial-mesenchymal transition via up-regulation of Snail in MCF7 human breast cancer cells.
    Zhang W; Feng M; Zheng G; Chen Y; Wang X; Pen B; Yin J; Yu Y; He Z
    Biochem Biophys Res Commun; 2012 Jan; 417(2):679-85. PubMed ID: 22166209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Up-regulation of vitamin D3 up-regulated protein 1 gene in response to 5-fluorouracil in colon carcinoma SW620.
    Takahashi Y; Nagata T; Ishii Y; Ikarashi M; Ishikawa K; Asai S
    Oncol Rep; 2002; 9(1):75-9. PubMed ID: 11748459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heat shock protein 27, a novel regulator of 5-fluorouracil resistance in colon cancer.
    Tsuruta M; Nishibori H; Hasegawa H; Ishii Y; Endo T; Kubota T; Kitajima M; Kitagawa Y
    Oncol Rep; 2008 Nov; 20(5):1165-72. PubMed ID: 18949417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-494 sensitizes colon cancer cells to fluorouracil through regulation of DPYD.
    Chai J; Dong W; Xie C; Wang L; Han DL; Wang S; Guo HL; Zhang ZL
    IUBMB Life; 2015 Mar; 67(3):191-201. PubMed ID: 25873402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitamin D mediates its action in human colon carcinoma cells in a calcium-sensing receptor-dependent manner: downregulates malignant cell behavior and the expression of thymidylate synthase and survivin and promotes cellular sensitivity to 5-FU.
    Liu G; Hu X; Chakrabarty S
    Int J Cancer; 2010 Feb; 126(3):631-9. PubMed ID: 19621386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of chemosensitivity of colorectal cancer to 5-fluorouracil by gene expression profiling with cDNA microarrays.
    Shimizu D; Ishikawa T; Ichikawa Y; Togo S; Hayasizaki Y; Okazaki Y; Danenberg PV; Shimada H
    Int J Oncol; 2005 Aug; 27(2):371-6. PubMed ID: 16010417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Choline kinase down-regulation increases the effect of 5-fluorouracil in breast cancer cells.
    Mori N; Glunde K; Takagi T; Raman V; Bhujwalla ZM
    Cancer Res; 2007 Dec; 67(23):11284-90. PubMed ID: 18056454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Down regulation of c-Myc and induction of an angiogenesis inhibitor, thrombospondin-1, by 5-FU in human colon cancer KM12C cells.
    Zhao HY; Ooyama A; Yamamoto M; Ikeda R; Haraguchi M; Tabata S; Furukawa T; Che XF; Iwashita K; Oka T; Fukushima M; Nakagawa M; Ono M; Kuwano M; Akiyama S
    Cancer Lett; 2008 Oct; 270(1):156-63. PubMed ID: 18583030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of microRNA-122 re-sensitizes 5-FU-resistant colon cancer cells to 5-FU through the inhibition of PKM2 in vitro and in vivo.
    He J; Xie G; Tong J; Peng Y; Huang H; Li J; Wang N; Liang H
    Cell Biochem Biophys; 2014 Nov; 70(2):1343-50. PubMed ID: 24898807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dihydropyrimidine dehydrogenase but not thymidylate synthase expression is associated with resistance to 5-fluorouracil in colorectal cancer.
    Nita ME; Tominaga O; Nagawa H; Tsuruo T; Muto T
    Hepatogastroenterology; 1998; 45(24):2117-22. PubMed ID: 9951876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of RhoGDI2 in the resistance of colon cancer cells to 5-fluorouracil.
    Zheng Z; Li J; He X; Chen X; Yu B; Ji J; Zhang J; Wang T; Gu Q; Zhu Z; Liu B
    Hepatogastroenterology; 2010; 57(102-103):1106-12. PubMed ID: 21410040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5-Fluorouracil: identification of novel downstream mediators of tumour response.
    Boyer J; Maxwell PJ; Longley DB; Johnston PG
    Anticancer Res; 2004; 24(2A):417-23. PubMed ID: 15152939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apoptosis, cell cycle progression and gene expression in TP53-depleted HCT116 colon cancer cells in response to short-term 5-fluorouracil treatment.
    Adamsen BL; Kravik KL; Clausen OP; De Angelis PM
    Int J Oncol; 2007 Dec; 31(6):1491-500. PubMed ID: 17982676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of lactate dehydrogenase A by microRNA-34a resensitizes colon cancer cells to 5-fluorouracil.
    Li X; Zhao H; Zhou X; Song L
    Mol Med Rep; 2015 Jan; 11(1):577-82. PubMed ID: 25333573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Upregulation of NOX-2 and Nrf-2 Promotes 5-Fluorouracil Resistance of Human Colon Carcinoma (HCT-116) Cells.
    Waghela BN; Vaidya FU; Pathak C
    Biochemistry (Mosc); 2021 Mar; 86(3):262-274. PubMed ID: 33838628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antitumor effect of 5-fluorouracil is enhanced by rosemary extract in both drug sensitive and resistant colon cancer cells.
    González-Vallinas M; Molina S; Vicente G; de la Cueva A; Vargas T; Santoyo S; García-Risco MR; Fornari T; Reglero G; Ramírez de Molina A
    Pharmacol Res; 2013 Jun; 72():61-8. PubMed ID: 23557932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The transfection of thymidylate synthase antisense suppresses oncogenic properties of a human colon cancer cell line and augments the antitumor effect of fluorouracil.
    Matsuoka K; Tsukuda K; Suda M; Kobayashi K; Ota T; Okita A; Watanabe K; Suzuki E; Murakami M; Doihara H; Shimizu N
    Int J Oncol; 2004 Jan; 24(1):217-22. PubMed ID: 14654960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-210-3p mediates metabolic adaptation and sustains DNA damage repair of resistant colon cancer cells to treatment with 5-fluorouracil.
    Pranzini E; Leo A; Rapizzi E; Ramazzotti M; Magherini F; Giovannelli L; Caselli A; Cirri P; Taddei ML; Paoli P
    Mol Carcinog; 2019 Dec; 58(12):2181-2192. PubMed ID: 31468617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell-cycle distribution and Thymidilate Synthatase (TS) expression correlate with 5-FU resistance in head and neck carcinoma cells.
    Ijichi K; Adachi M; Ogawa T; Hasegawa Y; Murakami S
    Anticancer Res; 2014 Jun; 34(6):2907-11. PubMed ID: 24922653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene expression profiling-based prediction of response of colon carcinoma cells to 5-fluorouracil and camptothecin.
    Mariadason JM; Arango D; Shi Q; Wilson AJ; Corner GA; Nicholas C; Aranes MJ; Lesser M; Schwartz EL; Augenlicht LH
    Cancer Res; 2003 Dec; 63(24):8791-812. PubMed ID: 14695196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.